Clinical Trial Update: A Study of LY3875383 in Healthy Participants and Participants With Hypertriglyceridemia [Phase 1]

View source ↗

Summary

A Phase 1 study of LY3875383 in healthy participants and individuals with hypertriglyceridemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• LY3875383

Snippet

Sponsor: Eli Lilly and Company | Conditions: Hypertriglyceridemia | Phase 1 | Status: TERMINATED